Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Decoy Therapeutics Inc., 3 years.
Decoy Therapeutics Inc.
Director
Omeros Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Decoy Therapeutics Inc. December 31, 202592.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Decoy Therapeutics Inc. | Grant or award | +3,000 | — | — |
| Aug 27, 2026 | Omeros Corporation | Option exercise | +2,500 | $15.81 | $39,525 |
| Aug 27, 2026 | Omeros Corporation | Option exercise | +7,500 | $14.66 | $109,950 |
| Aug 27, 2026 | Omeros Corporation | Open-market sale | −5,000 | $18.88 | $94,381 |
| Aug 27, 2026 | Omeros Corporation | Open-market sale | −5,000 | $19.02 | $95,081 |
| Aug 26, 2026 | Omeros Corporation | Option exercise | +5,000 | $15.81 | $79,050 |
| Aug 26, 2026 | Omeros Corporation | Open-market sale | −5,000 | $18.53 | $92,633 |
| Dec 30, 2025 | Decoy Therapeutics Inc. | Open-market sale | −15 | $0.64 | $10 |
| Dec 30, 2025 | Decoy Therapeutics Inc. | Open-market sale | −12 | $0.64 | $8 |
| Nov 20, 2025 | Decoy Therapeutics Inc. | Open-market purchase | +5,000 | $0.75 | $3,750 |
| May 22, 2023 | Omeros Corporation | Option exercise | +5,000 | $5.30 | $26,500 |
| May 22, 2023 | Omeros Corporation | Open-market sale | −5,000 | $6.46 | $32,300 |
| Jan 3, 2023 | Decoy Therapeutics Inc. | Grant or award | +1,440 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.